BRCA1/2 mutation carriers have a high lifetime risk of developing ovarian cancer (39% for BRCA1, 11–22% for BRCA2 at age 70 years) (Antoniou et al, 2003; Chen et al, 2006). This evidence concerns the gene BRCA2 and ovarian carcinoma.